From News Desk
As the EU adapts to global geopolitical tensions and renews its focus on simplifying legislation, Medicines for Europe convened policymakers, industry leaders and partners for its annual meeting in Brussels.
The conference was focused on “Building a Resilient Health Union – Security, Access and Competitiveness”. The agenda included critical topics such as the implementation of the EU Urban Wastewater Treatment Directive (UWWTD), the development of the Critical Medicines Act, the role of biotech and digitisation and the sustainability of procurement models and healthcare budgets. The discussions focused on how to strengthen Europe’s manufacturing base, secure access to affordable medicines and navigate the clean and digital transition while ensuring the access to medicines for people who depend on them every day.
Zentiva’s CEO, Steffen Saltofte, joined a panel on the topic “Delivering access to medicines in the context of the Clean Transition and One Health” – advocating for a clean transition that does not compromise access to medicines. With the support of local associations, German Progenerika and Czech CAFF, he presented reality checks from Germany and the Czech Republic, two of Zentiva’s key markets.
There is an urgent need to Pause – Repair – Relaunch, as the current implementation of the directive is unworkable for the generics industry.
“Sustainability is not just about the environment. It’s also about the sustainability of care – ensuring access to medicines to all people who depend on them every day, regardless of cost pressures. We need to find solutions that deliver on environmental sustainability and ensure access to affordable healthcare at the same time. Let’s not forget – health is a right, not a privilege,” Saltofte concluded.
Global Perspectives... 